Expression of Erk5 in Early Stage Breast Cancer and Association with Disease Free Survival Identifies this Kinase as a Potential Therapeutic Target

• Juan Carlos Montero ,

  Contributed equally to this work with: Juan Carlos Montero, Alberto Ocaña

  Affiliation Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca, Spain

  ⨯
• Alberto Ocaña ,

  Contributed equally to this work with: Juan Carlos Montero, Alberto Ocaña

  Affiliation Oncology Service and AECC Unit, Complejo Hospitalario Universitario de Albacete, Albacete, Spain

  ⨯
• Mar Abad,

  Affiliation Department of Pathology, Hospital Universitario de Salamanca, Salamanca, Spain

  ⨯
• María Jesús Ortiz-Ruiz,

  Affiliation Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca, Spain

  ⨯
• Atanasio Pandiella,

  Affiliation Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca, Spain

  ⨯
• Azucena Esparís-Ogando

  * E-mail: esparis@usal.es

  Affiliation Instituto de Biología Molecular y Celular del Cáncer, CSIC-Universidad de Salamanca, Salamanca, Spain

  ⨯